Monday, October 26, 2026 · Daily editionET --:--:--

Withdrawn before it began

Mobility and Therapeutic Benefits Resulting From Exoskeleton Use in a Home and Community Setting (SC140121 Study 3)

NCT04149769 · Vanderbilt University · Updated 9 Nov 2020

What is being tested
Indego Exoskeleton
For
Spinal Cord Injury
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. The full rules are on the registry page.
Where
United States (3 sites)
When
Starts or started 1 May 2020, ends 31 Dec 2020. Registered 4 Nov 2019.
Results
None posted yet.

In the researchers' words

The proposed study is a pilot study intended to inform the hypothesis that regular walking in an exoskeleton within the home and community might offer health benefit, neurological recovery, and/or mobility benefit to the user. This exploratory pilot study is also intended to assess the level of compliance (i.e., exoskeleton use) among study participants by characterizing extent the device is used beyond the minimum required.
ClinicalTrials.gov, NCT04149769

Sites

  • Tampa VATampa, Florida, United States
  • Minnesota Mayo ClinicRochester, Minnesota, United States
  • Vanderbilt University Medical CenterNashville, Tennessee, United States